Effective date: August 1, 2026 · Version 2.0
This Indemnity & Waiver Agreement (“Agreement”) applies to every purchaser (“you”) of products from Equora LLC (“Equora”). By placing an order and by checking the confirmation box at checkout, you accept this Agreement in addition to our Terms & Conditions.
1. Research use only
All products are for laboratory and research use only — not for human or veterinary consumption, and not for diagnostic, therapeutic, clinical, or cosmetic use. You confirm you are 21+ and a qualified researcher or licensed laboratory.
You further confirm that you will not resell, transfer, or supply the products to any person for human or veterinary use, and that you will store, handle and dispose of them in accordance with applicable law and good laboratory practice.
2. Assumption of risk
You assume all risk associated with the receipt, possession, handling, storage, use, and disposal of the products, and agree to follow all applicable laws and good laboratory practice.
You acknowledge that the products are supplied without any determination of safety or efficacy for any use, that they have not been approved by the U.S. Food and Drug Administration or any comparable authority, and that you are relying solely on your own professional judgement and that of your institution.
3. Waiver & release
To the fullest extent permitted by law, you waive and release Equora and its owners, officers, employees, agents, and suppliers from all claims, damages, or liabilities arising from your purchase, possession, handling, or use (or misuse) of the products.
This waiver and release applies to all claims of every kind and nature, whether known or unknown, including claims arising from or relating to the negligence of Equora or any of its owners, officers, employees, agents or suppliers, and including claims relating to the condition, identity, purity, labelling, packaging, storage or shipment of the products.
Nothing in this Agreement waives or limits liability that cannot lawfully be waived or limited, including liability for gross negligence, fraud, wilful misconduct, or personal injury caused by such conduct.
4. Indemnification
You agree to indemnify, defend, and hold harmless Equora and its owners, officers, employees, agents, and suppliers from any claim, loss, liability, or expense (including reasonable attorneys’ fees and costs of investigation) arising from your purchase, possession, handling, or use of the products, your breach of this Agreement, or your violation of any law.
Equora may select its own counsel and control its own defence at your expense. You may not settle any claim in a way that imposes any obligation or admission on Equora without its prior written consent.
5. Acknowledgement and record
By completing a purchase and checking the confirmation box at checkout, you acknowledge that you have read, understood, and agreed to this Agreement.
You agree that Equora’s record of that confirmation — including the version of this Agreement displayed, the date and time, and the associated order — is admissible evidence of your assent.
6. Governing law, venue and dispute resolution
This Agreement is governed by the laws of the State of Florida, without regard to its conflict-of-laws rules. The dispute resolution provisions of our Terms & Conditions, including the arbitration agreement and class-action waiver, apply to any dispute arising under this Agreement and are incorporated by reference.
7. Severability, survival and precedence
If any provision of this Agreement is held unenforceable, it will be modified to the minimum extent necessary to make it enforceable, or if it cannot be, severed, and the remaining provisions will continue in full force.
Sections 2, 3, 4, 6 and 7 survive completion, cancellation or refund of any order.
In the event of a conflict between this Agreement and the Terms & Conditions, this Agreement controls as to assumption of risk, release and indemnification, and the Terms & Conditions control as to all other matters.
This version supersedes the Indemnity & Waiver Agreement dated June 1, 2026.